SPRO
Spero Therapeutics, Inc. · Healthcare
Aquilo Capital Management, LLC bought $2.6M of Spero Therapeutics, Inc.
10% owner
Bought$2,630,175
$17.53Price
150,000Shares
+3%Stake
What SPRO did for a copier
- $1,000 copied at Wed, Nov 3 open, $18.21
- $719
- S&P 500, same days
- +1.1%
Measured over 30 trading days, to the Dec 16 close.
Aquilo Capital Management, LLC's record
12 other buys with 3 months of prices since 2021: on average −60.1% against the S&P 500, and 0 of 12 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Oct 29. Filed Tue, Nov 2, 5:47 PM ET, after the close. Returns use the Nov 3 open and the Dec 16 close. Not investment advice.